Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Rokx

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
HIV Medicine|October 2, 2018
Predictors of virological failure in HIV-1-infected patients switching to dolutegravir maintenance monotherapyIea Wijting, S L Rutsaert, C Rokx, et al.
International Journal of Antimicrobial Agents|December 5, 2022
Exposure and virologic outcomes of dolutegravir combined with ritonavir boosted darunavir in treatment-naïve individuals enrolled in the Netherlands Cohort Study on Acute HIV infection (NOVA)H A B Prins, L Zino, E M Svensson, et al.
AIDS and Behavior|June 13, 2024
Unmasking Individual and Institutional HIV Stigma in Hospitals: Perspectives of Dutch Healthcare ProvidersC C E Jordans, K J Vliegenthart-Jongbloed, A W van Bruggen, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|November 11, 2024
High acceptability of point-of-care HIV testing at the colposcopy outpatient clinic in hospitals in the NetherlandsR L O van de Laar, C C E Jordans, A Salmaan, et al.
The Journal of Antimicrobial Chemotherapy|February 5, 2021
The dolutegravir/valproic acid drug-drug interaction is primarily based on protein displacementP D J Bollen, H A B Prins, A Colbers, et al.
Journal of Virus Eradication|June 18, 2021
Launching a multidisciplinary European collaboration towards a cure for HIV: The EU2Cure ConsortiumC Rokx, H A B Prins, L Vandekerckhove, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
HIV Medicine|October 2, 2018
Predictors of virological failure in HIV-1-infected patients switching to dolutegravir maintenance monotherapyIea Wijting, S L Rutsaert, C Rokx, et al.
International Journal of Antimicrobial Agents|December 5, 2022
Exposure and virologic outcomes of dolutegravir combined with ritonavir boosted darunavir in treatment-naïve individuals enrolled in the Netherlands Cohort Study on Acute HIV infection (NOVA)H A B Prins, L Zino, E M Svensson, et al.
AIDS and Behavior|June 13, 2024
Unmasking Individual and Institutional HIV Stigma in Hospitals: Perspectives of Dutch Healthcare ProvidersC C E Jordans, K J Vliegenthart-Jongbloed, A W van Bruggen, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|November 11, 2024
High acceptability of point-of-care HIV testing at the colposcopy outpatient clinic in hospitals in the NetherlandsR L O van de Laar, C C E Jordans, A Salmaan, et al.
The Journal of Antimicrobial Chemotherapy|February 5, 2021
The dolutegravir/valproic acid drug-drug interaction is primarily based on protein displacementP D J Bollen, H A B Prins, A Colbers, et al.
Journal of Virus Eradication|June 18, 2021
Launching a multidisciplinary European collaboration towards a cure for HIV: The EU2Cure ConsortiumC Rokx, H A B Prins, L Vandekerckhove, et al.
Pageof 2